Miller D S, Ballon S C, Teng N N, Seifer D B, Soriero O M
Cancer. 1986 Feb 1;57(3):530-5. doi: 10.1002/1097-0142(19860201)57:3<530::aid-cncr2820570321>3.0.co;2-5.
Eighty-eight women with epithelial ovarian carcinoma, treated by first-line chemotherapy, achieved a complete clinical response and underwent second-look laparotomy to assess the true pathologic status of their disease. Persistent tumor was found in 50 patients (57%). Thirty-two of these (36%) had obvious gross tumor, whereas, 16 (18%) had microscopic disease. Thirty-eight patients (43%) had no pathologic evidence of persistent ovarian carcinoma. With a follow-up of 6 to 60 months, 30 of these patients (79%) remain without evidence of recurrence. Multivariate logistic regression analysis revealed three covariates that were independently significant in predicting continued disease-free status. These included: the greatest diameter of the largest residual tumor left at the primary operation; histologic features of the tumor; and the diameter of the largest tumor aggregate found at initial operation. A mathematical model based on the most significant covariates was designed to assess the relative risk of any patient having persistent tumor at second-look laparotomy. A comparison of the predicted to actual outcome revealed a sensitivity of the model of 88%, a specificity of 71%, and an accuracy of 77%. Second-look laparotomy represents the basis on which potentially curative second-line salvage therapy can be initiated. With an increasing period of follow-up and with greater numbers of patients, it can potentially document a complete pathologic response to first-line therapy administered with curative intent, and identify patients for additional, adjunctive therapy, who are at risk of recurrence.
88例接受一线化疗的上皮性卵巢癌女性患者获得了完全临床缓解,并接受了二次剖腹探查以评估其疾病的真实病理状态。50例患者(57%)发现有持续性肿瘤。其中32例(36%)有明显的肉眼可见肿瘤,而16例(18%)有微小病灶。38例患者(43%)没有持续性卵巢癌的病理证据。随访6至60个月,其中30例患者(79%)仍无复发迹象。多因素逻辑回归分析显示,有三个协变量在预测持续无病状态方面具有独立的显著性。这些因素包括:初次手术时残留的最大肿瘤的最大直径;肿瘤的组织学特征;以及初次手术时发现的最大肿瘤聚集体的直径。基于最显著协变量设计了一个数学模型,以评估任何患者在二次剖腹探查时出现持续性肿瘤的相对风险。预测结果与实际结果的比较显示,该模型的敏感性为88%,特异性为71%,准确性为77%。二次剖腹探查是启动潜在治愈性二线挽救治疗的基础。随着随访时间的延长和患者数量的增加,它有可能记录对以治愈为目的给予的一线治疗的完全病理反应,并识别有复发风险、需要额外辅助治疗的患者。